我是跑馬燈

專任教師

余兆武 副教授

研究領域:New drug development, Medicinal Chemistry, Organic Chemistry
電話:(02)33668698
信箱:stifenyu@ntu.edu.tw
本職:Chao-Wu Yu
個人網站:https://scholars.lib.ntu.edu.tw/cris/rp/rp199757

研究室成員 : 博士班:蔣心怡/黃鉉畯/楊宗諭/鄭孟宗/林柏叡
碩士班:李映璉,張詠淇/謝允晞,黃思涵,呂睿東
大學部:鄭靜茹, 黃浩軒
特助:巫賢修

曾參與的成員:

葉宗祐 (University of Wisconsin–Madison PhD)、邵麒軒(2022碩)
黃子祐 (University of Tennessee health science center)
林靖 (University of Michigan PhD)、蔡旻芙、劉雨琪(2023碩)
戴士軒 (2025碩)
招生名額 : 博士班一名 碩士班二名 產博一名
徵才 : 學士級或碩士級研究助理

Development and optimization of a zein-coated inhalable HDAC inhibitor formulation as a potential treatment for idiopathic pulmonary fibrosis via three-fluid nozzle spray drying
(2026-03) WEI-REN KE ; SHENG-CHIEH HSIAO ; MENG-TSUNG CHENG ; CHAO-WU YU

Establishing a noncanonical zinc-binding group as a selective histone deacetylase inhibitor and possible novel anticancer agent.
(2025-10) Huang, Hsuan-Chun ; Chen, Tse-Yu ; Yeh, Tsung-Yu ; Yu, Min-Hsuan ; Wu, Sian-Siou ; Li, Guang-Yi ; Chen, Bo-Yu ; MIAO-HSIA LIN ; Lin, Ching-Jung ; Hsu, Jui-Ling ; JIH-HWA GUH ; CHAO-WU YU

High-selective HDAC6 inhibitor alleviates bone marrow fibrosis through inhibiting collagen formation and extracellular matrix deposition.
(2025-08-01) Ke, Chiao-Hsu ; Huang, Mao-En ; Wu, Hsin-Yi ; CHAO-WU YU ; SHUEI-LIONG LIN ; Huang, Chih-Hung ; SHAU-PING LIN ; SHU-HAN YU ; CHEN-SI LIN

Design and synthesis of novel HDAC6 inhibitor dimer as HDAC6 degrader for cancer treatment by palladium catalysed dimerisation.
(2025) Lin, Ching ; Hsu, Jui-Ling ; Hsu, Yu-Tung ; Fan, Kuo-Chen ; Wu, Sian-Siou ; MIAO-HSIA LIN ; JIH-HWA GUH ; CHAO-WU YU

Discovery of novel anaplastic lymphoma kinase (ALK) and histone deacetylase (HDAC) dual inhibitors exhibiting antiproliferative activity against non-small cell lung cancer
(2024-12) Wang, Kang-Li ; Yeh, Tsung-Yu ; Hsu, Pei-Chen ; Wong, Tzu-Hsuan ; Liu, Jia-Rong ; JI-WANG CHERN ; MIAO-HSIA LIN ; CHAO-WU YU

more

Study the Effect and Mechanism of Novel Histone Deacetylase Inhibitors in Acute Kidney Injury-To-Chronic Kidney Disease
(2024-08-01~) SHUEI-LIONG LIN

Develop Novel Histone Deacetylase Inhibitors for Chronic Kidney Disease
(2023-08-01~) YUNG-MING CHEN

Develop Novel Histone Deacetylase Inhibitors for Chronic Kidney Disease
(2022-08-01~) YUNG-MING CHEN

Development of Novel Antibiotics against Bacterial Resistance through Characterizing the Bacterium-Specific Protein Phosphorylation and Acetylation Machinery
(2022-08-01~) MIAO-HSIA LIN

Novel Targeted Protein Degradation Platform: Small Molecule Anticancer Drug
(2022-01-01~) CHAO-WU YU

more